No description
-
2022 (v1)PublicationUploaded on: February 14, 2024
-
2020 (v1)Publication
To provide an updated assessment of the efficacy-safety profile of very short (1 or 3 months) dual antiplatelet therapy (DAPT) compared to long (12 months) DAPT in patients undergoing percutaneous coronary interventions (PCI).
Uploaded on: April 14, 2023 -
2020 (v1)Publication
To compare safety and efficacy of very short (≤3 months), short (6 months), standard (12 months) and extended (>12 months) DAPT, and subsequent monotherapies, after DES.
Uploaded on: April 14, 2023 -
2022 (v1)Publication
Aims: To describe the proportion of patients with syncope among those affected by hypertrophic cardiomyopathy (HCM) and the relevance of syncope as risk factor for sudden cardiac death and life-threatening arrhythmic events. Method and results: Systematic review of original articles that assessed syncope in HCM patients. Literature search of...
Uploaded on: February 6, 2024 -
2022 (v1)Publication
No description
Uploaded on: February 11, 2024